The Current Status of Cell-Based Therapies for Primary Knee Osteoarthritis

Orthop Clin North Am. 2019 Oct;50(4):415-423. doi: 10.1016/j.ocl.2019.06.001. Epub 2019 Aug 6.

Abstract

There is a growing interest in cell therapy for knee osteoarthritis. This study systematically reviews the current status of cell-based therapies. The authors review treatment modalities, clinical outcomes, and the economics of cell therapy. Inclusion criteria were articles containing cellular therapy, platelet-rich plasma, and knee osteoarthritis in the title. Letters, editorial material, abstracts not published, and manuscripts with incomplete data were excluded. Forty-two articles met these inclusion criteria and were critically reviewed. Cell-based therapy holds promise as a means of restoring deficient local cartilage cell populations. There is no evidence-based information for the use of cell-based therapies in knee osteoarthritis.

Keywords: Cell therapy; Conservative management; Knee osteoarthritis; PRP; Platelet-rich plasma; Stem cells.

Publication types

  • Review

MeSH terms

  • Cell- and Tissue-Based Therapy / economics*
  • Cell- and Tissue-Based Therapy / methods*
  • Cell- and Tissue-Based Therapy / standards
  • Cost-Benefit Analysis
  • Health Policy
  • Humans
  • Osteoarthritis, Knee / therapy*
  • Platelet-Rich Plasma / cytology
  • Randomized Controlled Trials as Topic
  • Stem Cell Transplantation
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration